{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih3d5jzcw6e5kbe2twqcmwpeprj773dqeuquop77rrcivuueyiiwa",
    "uri": "at://did:plc:lna3xh3vagib3abxsatsvfju/app.bsky.feed.post/3mf7sng3s4m42"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicdc3ipp2ct4onhfvy5ypzqi3rgzzcetd3wwczaxeqgkfmjh3wira"
    },
    "mimeType": "image/jpeg",
    "size": 4434
  },
  "path": "/nanotechnology-news3/newsid=68719.php",
  "publishedAt": "2026-02-19T11:55:03.000Z",
  "site": "https://www.nanowerk.com",
  "textContent": "Oral polysaccharide-engineered nanozyme treats colitis-linked mental disorders by targeting oxidative stress and gut dysbiosis via the microbiome-gut-brain axis.",
  "title": "Oral nanozyme treats colitis-linked mental disorders via gut-brain axis"
}